Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2016

01.08.2016 | Research Article

Factors influencing subjects’ comprehension of a set of medicine package inserts

verfasst von: Carla Pires, Marina Vigário, Afonso Cavaco

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background Package inserts (PIs) should promote the safe and effective use of medicines. The comprehension of PIs is related to socio-demographic features, such as education. Objectives To evaluate the participants’ comprehension of a sample of PIs and to build an explanatory model of subjects’ understanding of the content of these documents. Setting The data were collected from municipalities, city halls, firefighters, the military, schools and charities from two Portuguese regions. Methods Cross-sectional descriptive survey: 503 participants, homogeneously distributed by education and gender. The self-administered tool comprised questions on socio-demographic data, literacy tasks and comprehension evaluation of 12 purposively selected PIs. A logistic regression analysis was used. Main outcome measures Scores of numeracy tasks and comprehension. Results The average comprehension score for the PIs was 63 % (±32 %), with 48 % (n = 239) of the participants scoring <75 %. The most important predictors in explaining a comprehension score ≥75 % were having >12 years of education and correctly performing a numeracy task [respectively, OR 49.6 (CI 95 %: 22.8–108) and OR 2.48 (CI 95 %: 1.5–4.2)]. Conclusion An explanatory model of subjects’ knowledge about the content of the tested PIs was built. Given that a high level of education and literacy were found to be the most relevant predictors for acceptable comprehension rates, PIs should be clearly written to assure that they are understood by all potential users, including the less educated. The evaluated PIs may thus need to be simplified.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S. Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Fam Pract. 2014;15:163.CrossRefPubMedPubMedCentral Herber OR, Gies V, Schwappach D, Thürmann P, Wilm S. Patient information leaflets: informing or frightening? A focus group study exploring patients’ emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices. BMC Fam Pract. 2014;15:163.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–68.CrossRef Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page? Res Soc Adm Pharm. 2014;10(4):656–68.CrossRef
3.
Zurück zum Zitat Nicolson D, Knapp P, Raynor DK, Spoor P. Written information about individual medicines for consumers. Cochrane Database Syst Rev. 2009;15(2):CD002104. Nicolson D, Knapp P, Raynor DK, Spoor P. Written information about individual medicines for consumers. Cochrane Database Syst Rev. 2009;15(2):CD002104.
4.
Zurück zum Zitat Vinker S, Eliyahu V, Yaphe J. The effect of drug information inserts on patient behaviour. Isr Med Assoc J. 2007;9:383–6.PubMed Vinker S, Eliyahu V, Yaphe J. The effect of drug information inserts on patient behaviour. Isr Med Assoc J. 2007;9:383–6.PubMed
5.
Zurück zum Zitat Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–80.CrossRefPubMed Krska J, Morecroft CW. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf. 2013;36(8):673–80.CrossRefPubMed
6.
Zurück zum Zitat Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45(4):452–8.CrossRefPubMed Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45(4):452–8.CrossRefPubMed
7.
Zurück zum Zitat Pires C, Vigário M, Cavaco A. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49:1–13.CrossRef Pires C, Vigário M, Cavaco A. Readability of medicinal package leaflets: a systematic review. Rev Saude Publica. 2015;49:1–13.CrossRef
9.
Zurück zum Zitat McCarthy DM, Davis TC, King JP, Mullen RJ, Bailey SC, Serper M, et al. Take-Wait-Stop: a patient-centered strategy for writing PRN medication instructions. J Health Commun. 2013;18(1):40–8.CrossRefPubMedPubMedCentral McCarthy DM, Davis TC, King JP, Mullen RJ, Bailey SC, Serper M, et al. Take-Wait-Stop: a patient-centered strategy for writing PRN medication instructions. J Health Commun. 2013;18(1):40–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Al Juffali L, Al Omran O, Al Aqeel S. Saudi young patient understanding of information about side effects: Verbal versus numerical expression. Saudi Pharm J. 2014;22(1):33–7.CrossRefPubMed Al Juffali L, Al Omran O, Al Aqeel S. Saudi young patient understanding of information about side effects: Verbal versus numerical expression. Saudi Pharm J. 2014;22(1):33–7.CrossRefPubMed
11.
Zurück zum Zitat Knapp P, Raynor DK, Woolf E, Gardner PH, Carrigan N, McMillan B. Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations. Drug Saf. 2009;32(10):837–49.CrossRefPubMed Knapp P, Raynor DK, Woolf E, Gardner PH, Carrigan N, McMillan B. Communicating the risk of side effects to patients: an evaluation of UK regulatory recommendations. Drug Saf. 2009;32(10):837–49.CrossRefPubMed
12.
Zurück zum Zitat Gustafsson J, Kälvemark S, Nilsson G, Nilsson JL. Patient information leaflets—patients’ comprehension of information about interactions and contraindications. Pharm World Sci. 2005;27(1):35–40.CrossRefPubMed Gustafsson J, Kälvemark S, Nilsson G, Nilsson JL. Patient information leaflets—patients’ comprehension of information about interactions and contraindications. Pharm World Sci. 2005;27(1):35–40.CrossRefPubMed
13.
Zurück zum Zitat Knapp P, Wanklyn P, Raynor DK, Waxman R. Developing and testing a patient information booklet for thrombolysis used in acute stroke. Int J Pharm Pract. 2010;18(6):362–9.CrossRefPubMed Knapp P, Wanklyn P, Raynor DK, Waxman R. Developing and testing a patient information booklet for thrombolysis used in acute stroke. Int J Pharm Pract. 2010;18(6):362–9.CrossRefPubMed
14.
Zurück zum Zitat Dickinson D, Raynor DK, Duman M. Patient information inserts for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.CrossRefPubMed Dickinson D, Raynor DK, Duman M. Patient information inserts for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.CrossRefPubMed
15.
Zurück zum Zitat Miquel AV, Ortín F, Marrugat J, Pavesi M. Assessment of the comprehension of new rephrasing drug package inserts. Med Clin. 2000;115(11):410–7.CrossRef Miquel AV, Ortín F, Marrugat J, Pavesi M. Assessment of the comprehension of new rephrasing drug package inserts. Med Clin. 2000;115(11):410–7.CrossRef
16.
Zurück zum Zitat Raynor DK. User testing in developing patient medication information in Europe. Res Soc Adm Pharm. 2013;9(5):640–5.CrossRef Raynor DK. User testing in developing patient medication information in Europe. Res Soc Adm Pharm. 2013;9(5):640–5.CrossRef
17.
Zurück zum Zitat Fuchs J. The way forward in package insert user test from a CRO’s perspective. Ther Innov Regul Sci. 2010;44:119–29.CrossRef Fuchs J. The way forward in package insert user test from a CRO’s perspective. Ther Innov Regul Sci. 2010;44:119–29.CrossRef
18.
Zurück zum Zitat Roskos SE, Wallace LS, Weiss BD. Readability of consumer medication information for intranasal corticosteroid inhalers. Am J Health System Pharm. 2008;65(1):65–8.CrossRef Roskos SE, Wallace LS, Weiss BD. Readability of consumer medication information for intranasal corticosteroid inhalers. Am J Health System Pharm. 2008;65(1):65–8.CrossRef
20.
Zurück zum Zitat Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff. 2007;26(3):731–40.CrossRef Shrank WH, Avorn J. Educating patients about their medications: the potential and limitations of written drug information. Health Aff. 2007;26(3):731–40.CrossRef
21.
Zurück zum Zitat Ana B, Rosa A, Costa AF, Ávila P. A Literacia em Portugal: Resultados de uma Pesquisa Extensiva e Monográfica. [Literacy in Portugal: results of an extensive research and monograph]. Lisboa: Fundação Calouste Gulbenkian e Conselho Nacional de Educação, 1996, 27–119. ISBN 972-31-0713-9. Ana B, Rosa A, Costa AF, Ávila P. A Literacia em Portugal: Resultados de uma Pesquisa Extensiva e Monográfica. [Literacy in Portugal: results of an extensive research and monograph]. Lisboa: Fundação Calouste Gulbenkian e Conselho Nacional de Educação, 1996, 27–119. ISBN 972-31-0713-9.
26.
Zurück zum Zitat Pires C, Vigário M, Cavaco A. Package inserts of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study. Sao Paulo Med J. 2015;133(2):91–100.CrossRefPubMed Pires C, Vigário M, Cavaco A. Package inserts of the most consumed medicines in Portugal: safety and regulatory compliance issues. A descriptive study. Sao Paulo Med J. 2015;133(2):91–100.CrossRefPubMed
29.
Zurück zum Zitat Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30:607–10. Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30:607–10.
30.
Zurück zum Zitat Pires C, Vigário M, Cavaco A. Brand names of Portuguese medication: understanding the importance of their linguistic structure and regulatory issues. Cien Saude Colet. 2015;20(8):2569–83.CrossRefPubMed Pires C, Vigário M, Cavaco A. Brand names of Portuguese medication: understanding the importance of their linguistic structure and regulatory issues. Cien Saude Colet. 2015;20(8):2569–83.CrossRefPubMed
34.
Zurück zum Zitat Pires C, Cavaco A, Vigário M. Towards the definition of linguistic metrics for evaluating text readability in Portuguese (accepted by the J Quant Linguist in January 2016). Pires C, Cavaco A, Vigário M. Towards the definition of linguistic metrics for evaluating text readability in Portuguese (accepted by the J Quant Linguist in January 2016).
35.
Zurück zum Zitat Collins SA, Currie LM, Bakken S, Vawdrey DK, Stone PW. Health literacy screening instruments for eHealth applications: a systematic review. J Biomed Inform. 2012;45(3):598–607.CrossRefPubMedPubMedCentral Collins SA, Currie LM, Bakken S, Vawdrey DK, Stone PW. Health literacy screening instruments for eHealth applications: a systematic review. J Biomed Inform. 2012;45(3):598–607.CrossRefPubMedPubMedCentral
Metadaten
Titel
Factors influencing subjects’ comprehension of a set of medicine package inserts
verfasst von
Carla Pires
Marina Vigário
Afonso Cavaco
Publikationsdatum
01.08.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2016
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0305-6

Weitere Artikel der Ausgabe 4/2016

International Journal of Clinical Pharmacy 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.